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he term frontotemporal dementia (FTD)
1-3
refers to a complex of behavioral-cognitive symptoms
produced by progressive degeneration of the frontal
and/or temporal regions.
The syndrome originally described by Pick,
4 and thus
termed Pick’s disease in the following decades,was char-
acterized by atrophy and argentophilic intraneuronal
inclusions (Pick’s bodies).Indeed,the histopathological
features of the frontal dementias are not distinctive,and
a continuum towards other neurological conditions,such
as the tauopathies or motor neuron diseases, has now
been documented,
5,6 suggesting extensive pathological
and etiological heterogeneity.
In spite of this,there is quite a large consensus that the
clinical presentations of FTD should be restricted to
three main subtypes principally reflecting the distribu-
tion of neuronal loss,ie,of atrophy,in the brain:(i) the
behavioral or frontal variant (fv-FTD) due to prevalent
prefrontal damage,dominated by behavioral symptoms
and dysexecutive disorders; (ii) primary progressive
aphasia (PPA),
7 characterized by a progressive nonfluent
linguistic impairment associated with left perisylvian
atrophy;
8 and (iii) semantic dementia (SD), in which a
progressive agnosia for words and objects follows left
anterior temporal lobe degeneration.
9
Well-identified patterns of cognitive disorders, largely
confined to the linguistic domain,characterize the onset
of both PPA and SD,which are both generally compli-
cated by the emergence of behavioral manifestations
only at later stages.
10,11 On the other hand,the early man-
ifestation of the frontal variant frequently involves
noncognitive behavioral domains and personality
changes that may dominate the clinical picture for a long
time before true cognitive decline appears.
12 FTD is con-
sidered to be the second most frequent type of degener-
ative dementia.
13 However,it should be taken into con-
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Behavioral manifestations may dominate the clinical pic-
ture of the frontal variant of frontotemporal dementia (fv-
FTD) for a long time before the appearance of true cog-
nitive deficits. On the other hand, a deficit in the episodic
memory domain represents the main manifestation of
Alzheimer’s disease (AD). Many behavioral disorders have
been described in the clinical course of both FTD and AD;
however, apathy and personality changes characterize
frontal dementias, while depression dominates in AD, at
least in the earlier stages. Depending on the distribution
of neural damage, different patterns of noncognitive man-
ifestations may be expected in different subtypes of FTD.
Recent research on the social cognition deficit in FTD has
offered new insights into the relationship between cog-
nition and behavior, suggesting that some aspects of the
behavioral changes in dementia may be generated by
impairment in this domain. 
© 2007, LLS SAS Dialogues Clin Neurosci. 2007;9:153-160.sideration that the noncognitive nature of the onset man-
ifestations in the frontal variant probably contributes to
an underestimation of its true prevalence.
14,15 Regarding
the most frequent degenerative dementia,Alzheimer’s
disease (AD), a cognitive deficit, principally in the
episodic memory domain,represents its typical onset and
remains the core feature of the syndrome for the entire
clinical course; noncognitive disorders are only occa-
sionally early symptoms,but become more frequent and
stable as the disease progresses.
16
In the past, the cognitive disorder has by far been the
main focus of clinical studies on AD.Only in the last two
decades has systematic investigation of the noncognitive
manifestations of this type of dementia become possible,
thanks to the publication of structured scales for their
assessment.
17,18
One could say that clinical research on cognitive-behav-
ioral disorders in dementia has followed different routes
in AD and FTD. Although behavioral manifestations
have been reported in AD since its original description,
it has been considered to be a disease involving primar-
ily the cognitive systems,and thus “dementia”by defin-
ition.Interest in the behavioral disorders is more recent.
FTD was initially mistaken for AD and for psychiatric
diseases.It has only recently been rediscovered,
19,20 and
because of the presence of a clear noncognitive compo-
nent in the symptomatology (at least in the frontal vari-
ant) it has been,since the earliest reports,considered to
be a behavioral-cognitive syndrome.
Noncognitive disorders in AD have been diffusely
investigated, and a large number of descriptions have
become available in the past decade. However, most
reports on the behavioral disturbances in FTD have not
specifically focused on this type of dementia; they are,
in fact, comparative studies between AD and FTD. In
addition, since the scales for assessing the behavioral
deficit were originally devised for AD, it is likely that
disorders more specific to FTD were not sufficiently
identified until diagnostic tools were devised explicitly
for FTD.
For many reasons,studies of behavioral disturbances in
dementia are often difficult to compare. First of all,
reports largely reflect the tool adopted for assessing the
syndrome.In addition,groups in which studies have been
conducted may be heterogeneous, either for disease
severity and clinical expression,or the selection criteria
adopted to group the patients. Misdiagnoses seriously
hinder achieving a reliable description and a quantifica-
tion of the behavioral manifestation.The use of standard
diagnostic criteria for patient selection does not in fact
guarantee a correct diagnosis,
21,22 and autopsy confirma-
tion should be obtained.However,only in a minority of
reports is the diagnosis supported by pathology. For
example,inclusion of patients with dementia with Lewy
bodies (DLB) in AD groups is likely to produce an over-
estimation of the frequency of hallucinations in this form
of dementia.
Finally,studies not corroborated by pathological data are
necessarily tautological to some extent. For example,
since the presence of behavioral disorders constitutes a
diagnostic criterion for FTD,
3 only FTD patients with
behavioral disorders are selected for inclusion,and this
could artificially increase their true frequency. At the
same time,symptoms not specifically mentioned in the
diagnostic criteria adopted are misidentified,and their
occurrence is thus underestimated.
The assessment of behavioral disturbances also suffers
from other limitations compared with the assessment of
cognitive disorders.Symptom detection and quantifica-
tion are not based on direct observation of patients and
mostly rely on caregivers' reports,and the influence care-
givers' variables may have on symptom description and
quantification is not always adequately taken into
account.
Noncognitive disorders in AD and FTD: 
a brief review
AD
Many behavioral disorders have been reported in AD
patients,ranging from mood changes to psychoses and to
modification in social conduct.
18,23,24There may be several
explanations for this heterogeneity.First,the disease itself
is heterogeneous in its noncognitive manifestations.
Occasionally,noncognitive disorders may characterize
the onset.
25The behavioral manifestation,however,may
emerge at any stage of the disease,and it tends to worsen
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Selected abbreviations and acronyms
AD Alzheimer's disease
DLB dementia with Lewy bodies
FTD frontotemporal dementia
fv-FTD frontal variant of frontotemporal dementia
SD semantic dementia
TofM theory of mindover time;fluctuations have also been reported.
26Thus,
presence and severity of symptoms largely depend on the
stage at which the patient has been observed. Second,
methodological reasons may also contribute to hetero-
geneity.Only in the last decade have symptom detection
and quantification been evaluated by means of struc-
tured or semistructured scales,validated in large groups
of patients.This has allowed for more objective descrip-
tions of symptoms, as well as attempts to compare dif-
ferent reports.Nevertheless,the prevalence rate seems to
be still largely influenced by the clinical diagnostic crite-
ria used for evaluation.
27 Finally,since a few reports are
corroborated by postmortem pathological confirmation,
misdiagnoses should be considered as a potential cause
of heterogeneity.For example,if the temporal variant of
FTD is erroneously included in AD dementia groups
(differential diagnosis may not be easy at earlier stages)
manifestations of this type of dementia might,indeed,be
considered proper to AD.
There is some agreement in considering major depres-
sion and,in general,the affective disorders,as common
symptoms either at the onset
28 and throughout the entire
clinical course of AD.
29-34 Pathological anxiety is also
reported.
35 The average frequency of depression is
approximately 40% (see ref 36 for a review) even if its
prevalence seems to decrease over time.
37 Apathetic
behavior,which is significantly correlated with but dis-
tinct from depression,
38,39 also seems to be widely repre-
sented in AD
40 and is considered as a factor predicting
more aggressive dementia.
41 Psychotic symptoms, and
specifically delusions and hallucinations, are also
described as frequent manifestations in the clinical
course of AD,
42-45 mostly in later stages.
46 Paranoid
misidentifications, such as in Capgras’ syndrome, have
also been occasionally reported.
47
The emergence of psychotic symptoms is currently con-
sidered to predict faster cognitive and functional
decline
48-53 as well as increased risk of mortality,
54 even if
some studies lead to different conclusions.
55A relation-
ship between psychotic symptoms,age at onset,and dis-
ease duration has also been pointed out by some authors
(see ref 56 for a review).Currently,there are descriptions
of other noncognitive symptoms,primarily pathological
conduct,which merge into a large variety of syndromes.
57
Agitation,aggression,
58-60 aberrant motor behavior and
wandering,
57 sleep and eating disorders,
61,62 and impaired
insight
63 are frequently described in association with
depression or psychoses.
FTD 
As previously mentioned,most research on noncognitive
disorders in FTD consists of comparative studies
between the two most frequent forms of dementia,AD
and FTD.Only in more recent years have comparisons
been made with vascular dementia,
64,65 DLB, or
Parkinson's disease.
66
From the time of the first reports on FTD,
68 alteration of
social conduct,reduced insight,personality changes,and
apathy have been described as core features of the dis-
ease and have been included in the diagnostic criteria.
3
Behavioral alterations seem generally more severe in
FTD than in AD
69-71 and a relationship with patient’s gen-
der and age has been hypothesized.
72 Descriptions are
quite consistent throughout the literature,in spite of the
use of different scales for symptom detection.
Not only severity,but also symptom patterns,seem to dif-
ferentiate the two dementias.Both “negative”symptoms
such as apathy,loss of insight,indifference,and personal
neglect,and “positive”symptoms such as disinhibition,
impulsivity,euphoria,and aberrant motor behavior pre-
vail in FTD,
14,15,64,72-74 while depression is confirmed to be
more characteristic of AD.
72 Reports of apathy are espe-
cially consistent in FTD
74-77 and are documented through-
out the disease course.
78 Repetitive behavior, ranging
from motor stereotypes to complex obsessive-compul-
sive disorders,is also reported as a dominant manifesta-
tion,
10,71,74 and,according to some authors,as the present-
ing symptom.
79 Eating disorders are also considered
typical in this dementia
78 and more common than in
AD.
64,65,76,80 Changes in food preferences towards sweet
foods and an increase in appetite
10,64,81,82 have been
reported in studies providing more detailed descriptions.
Frontal vs temporal variant and right vs left atrophy in
FTD
From the onset,pathological processes may be distrib-
uted asymmetrically in the frontal region,
83 determining
variability in the clinical manifestation.Behavioral dis-
orders do not seem significantly different in the frontal
vs temporal variant (semantic dementia)
10,71,84 or PPA,
11
even if they tend to manifest earlier in the frontal vari-
ant.
10,11 However, some differences have been pointed
out. For example, apathy
74,84 and stereotypes
74 are
described as being more frequent in the frontal com-
pared with the temporal variant,while sleep disorders
84
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drome,dominated by oral exploratory behavior,hyper-
phagia,and hypersexuality,
80 are more likely to manifest
in the temporal variant.
80
Studies on FTD do not generally take into consideration
the issue regarding left vs right asymmetry of atrophy dis-
tribution.Indirect evidence about the characteristics of
the behavioral syndrome in asymmetric-left atrophy can
be obtained by observing patients with SD and PPA in
which linguistic disorders suggest left-sided involvement.
Similarly,a few papers are also available on FTD patients
in whom cognitive symptoms suggest a prevalent right
pathology.In general,although the pattern of cognitive
impairment is largely consistent with the distribution of
atrophy,
69,85 mostly when the diagnosis of PPA or seman-
tic dementia (temporal variant) is made,
10 the influence
of left-right asymmetry is less predictable in the behav-
ioral domain.Only a few studies have specifically com-
pared the behavioral syndrome of patients with preva-
lent left or right hemispheric atrophy.Disinhibition,
69,84
but also anxiety,depression,and eating disorders
84 have
been associated with right-asymmetric frontotemporal
atrophy. Greater attention has been given to patients
with right frontotemporal pathology in studies investi-
gating “high-level”activities that might be located at the
interface between cognition and behavior,such as activ-
ities related to social cognition.
86,87This issue will be dis-
cussed later.
Impairment of different cortical subcortical prefrontal
circuits: different cognitive-behavioral syndromes? 
Three cortical subcortical circuits are supposed to under-
lie cognition and behavior in the prefrontal lobe.While
the dorsolateral prefrontal circuit is postulated to be
involved in cognitive activities proper,primarily planning
and attention,the orbitofrontal and anterior cingulate
(dorsomedial) circuits are likely involved in behavior.In
particular, social cognition and empathy require the
integrity of the orbitofrontal circuit,while motivation is
accomplished by the anterior cingulate circuit.It is plau-
sible that degeneration involves these neural subsystems
in disease evolution differently,giving rise to different
cognitive-behavioral patterns.Indeed,this is confirmed
by clinical evidence.For example,it is well known that
the behavioral manifestations greatly precede the cogni-
tive deficits in some patients,and this is to some extent
consistent with the relative preservation,in early stages,
of the dorsolateral circuit.Functional studies conducted
in fv-FTD are also consistent with this view.Metabolic
involvement of separate brain clusters has recently been
demonstrated.
88The metabolic involvement of the lateral
and medial prefrontal cortex has been related to
impaired cognitive abilities (memory and executive abil-
ity),
88 while an orbitofrontal dysfunction has been corre-
lated to behavioral disorders such as disinhibition and
apathy.
89
Relationship between cognitive and 
noncognitive symptoms in dementia
The relationship between cognitive and behavioral dis-
orders is a central issue in all types of dementia.
However,while studies on AD are mostly descriptive and
focused on clinical aspects, recent studies on FTD are
more speculative.
Although there is little evidence suggesting that the cog-
nitive and behavioral manifestations in AD are inde-
pendent of each other,
90 many studies report data in sup-
port of a relationship (at least quantitative) between the
severity of cognitive and behavioral syndromes. For
example,the severity of the behavioral disorders is pre-
dicted by the severity of the cognitive deficit.
91 Further,
the presence of delusions and hallucinations has been
considered predictive of a more severe cognitive disor-
der, and in general of a faster dementia evolu-
tion.
26,42,44,53,54,92 On the other hand,there is some evidence
that in more severe dementia depression is less severe.
57
However,research primarily reports quantitative data,
and only occasionally have hypotheses been advanced on
a possible causal relationship between specific cognitive
deficits and specific patterns of behavioral manifesta-
tions. Reduced ability on cognitive tasks sensitive to
frontal lobe damage seems to be associated with a higher
risk of psychotic symptoms in AD,
43,48 supporting the
hypothesis that symptoms such as hallucinations and
delusions could be produced by pathological frontal cir-
cuitry.Correlation between “frontal”tasks and psychotic
symptoms has also been demonstrated in patients with
FTD,
93 confirming that, independently of the type of
dementia,frontal lobe involvement is the main requisite
for the appearance of behavioral manifestations.
Generally, however, studies do not explicitly take into
account the potential cause-effect relationship between
the two types of manifestations. Namely, although
hypothesized, it has never been specifically explored
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be traced back to the same neural damage,or whether
behavioral disorders might to some extent represent a
“reaction”to the cognitive deficit.Indeed,it is likely that
any limitation of cognitive resources could reduce a
patient’s ability to efficiently react to environmental stim-
ulation in order to generate adequate behavioral
responses.The memory disorder, to mention the most
common example, typical of AD but also frequent in
other types of dementia,might produce such severe func-
tional limitation as to generate reactive depression in
amnesic subjects with good insight.
Theory of mind and behavior in FTD
The hypothesis of a direct relationship between cognition
and behavior in FTD is now currently proposed in the
neuropsychological literature.In particular,it has been
proposed that the impairment of “high-level” compe-
tences of the frontal lobe might generate behavioral
changes, mostly in personality and social conduct.
Particular attention has been devoted to the theory of
mind (TofM). TofM is the ability to make inferences
about others’ mental states, thoughts, and feelings in
order to predict and understand their behavior.TofM is
strictly related to the concept of “empathy,”that is,the
ability to spread emotions to other people and to under-
stand other people’s emotions.A deficit in TofM,origi-
nally proposed to account for developmental disorders
in social cognition of subjects affected by pathologies
such as autism or Asperger’s syndrome,
94,95 could also
explain some aspects of the pathological behavior typi-
cal of patients with FTD.The effects of frontal lobe dam-
age on behavior, and in particular of damage in the
orbital and ventral regions,have long been known.
96The
neurocircuitry of TofM has been delineated by both
lesional and functional studies.There is basic agreement
in considering the amygdala
97 and the orbitofrontal cor-
tex,
95 and also the medial prefrontal cortex
98 as the
anatomical base for TofM (see also ref 99).A few reports
have specifically taken into consideration the relation-
ship between impaired TofM and behavioral disorders in
patients with FTD.Gregory et al
100 demonstrated a sig-
nificant negative correlation between the score obtained
on the more sophisticated TofM tasks and the
Neuropsychiatric Inventory (NPI) in FTD (but not in
AD). They interpreted this finding as supporting the
hypothesis that some aspects of the changes in interper-
sonal behavior typical of this pathology might be caused
by impaired TofM.Interestingly,confirming a previous
report,
101 performance on TofM tasks was largely inde-
pendent of performance on tasks measuring “conven-
tional” cognitive frontal abilities, first of all, executive
tasks.Correlation between TofM and NPI,as well as dis-
sociation between TofM and executive functions (see also
ref 97),suggests that TofM tasks should not be consid-
ered simply as a measure of the cognitive skill of the
frontal lobe,namely of executive function.Rather,they
should be considered as reflecting the ability to under-
stand mental states,crucial for generating normal inter-
personal behavior.It has also been demonstrated that the
reduced competence shown by FTD patients in under-
standing emotions (empathy) and social transgressions is
not fully accounted for by the documented impairment
in executive tasks,confirming the independence of social
and cognitive abilities.
102The recently formulated hypoth-
esis on the existence of dissociable emotional and cogni-
tive components of TofM
103 could also contribute to a bet-
ter interpretation of the relationship between cognition
and behavior in FTD.
Metacognition and behavior in FTD
Metacognition refers to high-level processing that con-
sists of planning,self-evaluation,and self-monitoring of
cognitive activities.Deficits in self-regulatory behavior,
deriving from a lack of metacognitive control on execu-
tive abilities,have been related to prefrontal lesions.
Recently, this aspect was investigated in patients with
FTD,and mostly patients with the frontal variant showed
poor self-awareness and self-knowledge,not only in cog-
nitive but also in emotional and social domains.
87
Conclusion
FTD and AD are both characterized by a wide range of
behavioral disorders.However,in contrast to AD,in FTD
they may manifest when cognition is still relatively pre-
served. This allows for their observation without the
“noisy”effects of the cognitive impairment.The neural
correlates of noncognitive manifestations are more iden-
tifiable in FTD,and refer to specific cortical subcortical
circuits in the prefrontal regions.Thus,“frontal”behav-
ioral syndromes might be viewed as “system”pathologies
and might offer information complementary to that
derived from subjects with focal lesions.For these rea-
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tion to defining the neural basis of human behavior,and
also offer a model for studying behavioral disorders in
other forms of dementia.
From the clinical point of view,the possibility of identi-
fying specific patterns of cognitive-behavioral symptoms
would be very relevant in the differential diagnoses of
dementia, mostly in the absence of reliable biological
markers.
Newly proposed investigations in the social cognition
domain such as TofM,but also metacognition
87 or deci-
sion-making,
104 may offer further opportunities for inter-
preting the nature of the behavioral manifestations and
their relationship to cognitive disorders.The correlation
some authors have found between tasks exploring social
cognition,primarily TofM,and standardized measures of
behavioral impairment,has a potentially useful clinical
application.Until now,detection and quantification of
behavioral changes have relied almost exclusively on
caregivers’ reports in structured questionnaires aimed
toward defining specific symptoms or syndromes.
Quantifying the severity of the social cognition disorder
could provide a direct measure of the severity of the
behavioral manifestation in dementia.This perspective
should encourage the development of specific test bat-
teries for investigating this area. ❏
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Desde la demencia frontotemporal a la
Enfermedad de Alzheimer
Previo a la aparición de los verdaderos déficits cog-
nitivos, las manifestaciones conductuales pueden
dominar por un largo tiempo el cuadro clínico de la
variante frontal de la demencia frontotemporal (DFT-
vf). Por otra parte, un déficit en el área de la memo-
ria episódica representa la principal manifestación
de la Enfermedad de Alzheimer (EA). Se han descrito
muchos trastornos conductuales durante el curso clí-
nico tanto de la DFT como de la EA; sin embargo, la
apatía y los cambios de personalidad caracterizan a
las demencias frontales, mientras que la depresión
domina en la EA, al menos en las primeras etapas.
Dependiendo de la distribución del daño neural, se
pueden esperar diferentes patrones de manifesta-
ciones no cognitivas en los diferentes subtipos de
DFT. Investigación reciente sobre el déficit cognitivo
social en las DFT ha entregado nuevos conocimien-
tos acerca de la relación entre cognición y conducta,
lo que sugiere que algunos aspectos de los cambios
conductuales en la demencia pueden ser generados
por deterioro en esta área. 
De la démence frontotemporale à la maladie
d’Alzheimer
Des signes comportementaux peuvent dominer le
tableau clinique de la variante frontale de la
démence frontotemporale (vf-DFT) longtemps
avant l’apparition des véritables déficits cognitifs.
Par ailleurs, un déficit au niveau de la mémoire épi-
sodique constitue le symptôme principal de la mala-
die d’Alzheimer (MA). L’évolution clinique de la DFT
et de la MA comporte de nombreux troubles com-
portementaux ; l’apathie et les changements de
personnalité caractérisent les démences frontales,
alors que la dépression prévaut dans la MA, au
moins aux stades précoces. Différents schémas de
troubles non cognitifs peuvent se manifester dans
des sous-types multiples de DFT, selon la localisation
des lésions nerveuses. Une nouvelle réflexion sur le
lien entre la cognition et le comportement, grâce à
une recherche récente sur le déficit en cognition
sociale dans la DFT, suggère que certains aspects des
transformations comportementales au cours de la
démence pourraient être provoqués par des dété-
riorations dans ce domaine. 
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